Concepedia

Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma

Dennis F. Moore, Richard Pazdur, J. L. Abbruzzese, Jaffer A. Ajani, D Dubovsky, James L. Wade, Robert J. Belt, C. Mangold, R. J. Winn

Annals of Oncology · 1994 · 17 citations · 5 references

DOI

Concepts

References

5

Comprehensive Criteria for Assessing Therapy-Induced Toxicity

Jaffer A. Ajani, Susan Welch, Martin N. Raber et al. · Cancer Investigation · 1990 · 240 citations

, , +17

New folate analogs of the 10-deaza-aminopterin series

Francis M. Sirotnak, Joseph I. DeGraw, Franz A. Schmid et al. · Cancer Chemotherapy and Pharmacology · 1984 · 137 citations

, , +9

Phase I trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer.

Mark G. Kris, James J. Kinahan, Richard J. Gralla et al. · PubMed · 1988 · 56 citations

, , +14

Phase II study of 10-ethyl-10-deaza-aminopterin (10-EdAM; CGP 30 694) for stage IIIB or IV non-small cell lung cancer

Jin S. Lee, Herman I. Libshitz, William K. Murphy et al. · Investigational New Drugs · 1990 · 33 citations

, , +12

Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma

Ephraim S. Casper, Gary K. Schwartz, Bruce E. Johnson et al. · Investigational New Drugs · 1992 · 21 citations

, , +11